Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Accounts Payables (2016 - 2025)

Dexcom (DXCM) has disclosed Accounts Payables for 16 consecutive years, with $1.9 billion as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 22.64% to $1.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 billion through Dec 2025, up 22.64% year-over-year, with the annual reading at $1.9 billion for FY2025, 22.64% up from the prior year.
  • Accounts Payables for Q4 2025 was $1.9 billion at Dexcom, up from $1.9 billion in the prior quarter.
  • The five-year high for Accounts Payables was $1.9 billion in Q4 2025, with the low at $482.0 million in Q2 2021.
  • Average Accounts Payables over 5 years is $1.2 billion, with a median of $1.3 billion recorded in 2023.
  • The sharpest move saw Accounts Payables skyrocketed 87.89% in 2021, then grew 15.98% in 2024.
  • Over 5 years, Accounts Payables stood at $573.0 million in 2021, then soared by 57.38% to $901.8 million in 2022, then soared by 49.2% to $1.3 billion in 2023, then rose by 17.81% to $1.6 billion in 2024, then rose by 22.64% to $1.9 billion in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $1.9 billion, $1.9 billion, and $1.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.